- The EMA at 20: CHMP chair on HTA, patient involvement and dealing with uncertainty
- STOCKWATCH: EU conditional approvals – what gives?
- CHMP nod for Chiesi's Holoclar, Europe's first stem cell therapy
- German HTA slams cagey Chiesi disclosure on Glybera bad news
ANALYSIS Other Informa Analysis
- INTERVIEW: Clinuvel's Philippe Wolgen on Scenesse and the patient factor
- Profile: Janssen R&D boss on the next big thing in medicine & 'ice bucket' funding